Ozempic’s active ingredient is semaglutide, a lab-engineered version of a hormone your body naturally produces called GLP-1. Each milliliter of the injection solution contains 1.34 mg of semaglutide along with a handful of inactive ingredients: disodium phosphate dihydrate, propylene glycol, phenol, and water. But the real story is in how semaglutide itself is built and why its specific chemical design makes it so different from the natural hormone it mimics.
The Active Ingredient: Semaglutide
Semaglutide is a 31-amino-acid peptide, a short chain of protein building blocks modeled after a gut hormone called GLP-1 (glucagon-like peptide-1). Your body releases natural GLP-1 after eating, and it signals the pancreas to produce insulin, slows digestion, and reduces appetite. The problem is that natural GLP-1 breaks down in minutes, far too quickly to work as a medication. Semaglutide solves this with three key modifications to the natural molecule.
First, the amino acid at position 8 is swapped out for a synthetic one called alpha-aminobutyric acid. This single change makes the molecule resistant to an enzyme called DPP-4 that would otherwise chop it apart almost immediately. Second, the amino acid at position 34 is replaced with arginine. Third, and most importantly, a long fatty acid chain is chemically attached to the amino acid at position 26. This fatty acid is an 18-carbon diacid connected through a series of small chemical spacers. It’s this fatty tail that gives semaglutide its week-long staying power in the body.
Why the Fatty Acid Chain Matters
The fatty acid chain attached to semaglutide acts like an anchor. Once injected, it latches onto albumin, the most abundant protein in your blood. Albumin is large and long-lived, and by hitching a ride on it, semaglutide avoids being filtered out by the kidneys and broken down by metabolic enzymes. This albumin binding is the primary reason semaglutide has a half-life of about a week, which is why you only inject Ozempic once every seven days. The fatty chain also slows absorption from the injection site itself, creating a gradual release into the bloodstream rather than a sudden spike.
How Semaglutide Is Made
Semaglutide isn’t synthesized purely in a chemistry lab. It’s produced using a biological process that starts with genetically engineered baker’s yeast (Saccharomyces cerevisiae). Through recombinant DNA technology, yeast cells are programmed to produce a precursor version of the semaglutide peptide during a fermentation step. This precursor is then recovered, isolated, and purified from the yeast culture.
After purification, the peptide backbone goes through a chemical modification step. The fatty acid chain with its spacers is attached at the lysine residue at position 26. Then, a small two-amino-acid fragment is joined to the front end of the molecule to complete the final structure. This hybrid approach, part biological fermentation and part chemical modification, is one reason semaglutide is difficult and expensive to manufacture. It’s also why compounding pharmacies have struggled to replicate it reliably.
Inactive Ingredients in the Pen
The solution inside an Ozempic pen contains more than just semaglutide. Each milliliter includes:
- Disodium phosphate dihydrate (1.42 mg): a buffering agent that keeps the solution at a stable pH of 7.4, close to the pH of your blood
- Propylene glycol (14.0 mg): a tonicity agent that ensures the solution matches the concentration of your body fluids so the injection doesn’t sting or damage tissue
- Phenol (5.50 mg): a preservative that keeps the solution sterile between uses, since each pen is used for multiple doses over several weeks
- Water for injections: the solvent that dissolves everything into a clear, injectable solution
Hydrochloric acid and sodium hydroxide are also used during manufacturing to fine-tune the pH to exactly 7.4, though they’re present in trace amounts in the final product.
Different Pen Concentrations
Ozempic pens come in three concentrations to deliver different weekly doses. The lowest-strength pen contains 2 mg of semaglutide in 3 mL of solution (0.68 mg/mL) and delivers either a 0.25 mg or 0.5 mg dose per injection. The mid-strength pen holds 4 mg in 3 mL (1.34 mg/mL) and delivers 1 mg per injection. The highest-strength pen contains 8 mg in 3 mL (2.68 mg/mL) for 2 mg doses. The inactive ingredients remain the same across all three. The pen itself dials in the correct volume automatically, so you don’t need to measure anything.
How This Differs From Natural GLP-1
Natural GLP-1 is a fragile molecule. Your body produces it in the intestines after meals, and enzymes destroy it within two to three minutes. It never builds to high sustained levels in your blood. Semaglutide, by contrast, circulates continuously for days. The amino acid swap at position 8 blocks the enzyme that would degrade it. The fatty acid chain keeps it bound to albumin and out of reach of your kidneys. And the arginine substitution at position 34 prevents the fatty chain from attaching in the wrong spot during manufacturing. Together, these three modifications turn a molecule that lasts minutes into one that works for a full week, all while activating the same GLP-1 receptor that the natural hormone targets.